JNK信号通路对蜂胶抑制白血病K562细胞增殖的调控作用

目的探讨JNK信号通路对蜂胶抑制K562细胞增殖过程的调控作用。方法体外培养K562细胞,用不同浓度蜂胶、c—Jun氨基末端激酶（c—JanN—terminalkinase,JNK）特异性抑制剂SP600125对白血病K562细胞进行处理,用MTT法检测细胞增殖抑制率,流式细胞术（FCM）检测细胞凋亡率,Western印迹检测JNK下游分子c—Jun以及磷酸化c—Jan（p-c-Jun）的变化。结果蜂胶作用K562细胞后,增殖抑制率、凋亡率显著升高,具有时间和剂量依赖性,并伴随p-c-Jun蛋白水平上调;加入SP600125能下调p-c-Jun的水平,显著提高蜂胶对K562细胞的增殖抑制率和凋亡率。结论JNK信号通路参与了蜂胶抑制K562细胞增殖过程的调控。抑制JNK活性可增强蜂胶对K562细胞的增殖抑制、凋亡诱导作用。     

铁剥夺在TPA 诱导K562 细胞分化中对细胞 生长分化及EGR1mRNA 表达的影

目的：通过,IPA诱导K562细胞分化过程中干预细胞铁代谢探讨白血病细胞铁与细胞分化的关系及对EGR1mRNA表达的影响。方法：应用体外细胞培养技术通过细胞形态,细胞化学染色观察细胞生长分化情况;用FCM、RT—PCR等技术检细胞周期、细胞表面分化抗原CD33、CD14及EGR1mRNA的表达。结果：在,IPA诱导K562细胞分化过程中铁剥夺可明显抑制K562细胞生长,并可阻止,IPA诱导K562细胞分化,使K562细胞停止在S期。铁剥夺可降低,TPA诱导K562细胞分化过程中EGR1mRNA的表达。讨论：铁剥夺明显抑制K562细胞生长、阻止TPA诱导K562细胞分化,故铁剥夺剂（DFO）可能作为一种辅助抗癌药用于白血病的化疗,但由于它能阻止白血病细胞的分化,故不宜用于白血病的诱导分化治疗。铁剥夺使K562细胞分化过程中E—GR1mRNA表达降低可能参与了阻止TPA诱导K562细胞的分化过程。     

DC-CIK对K562/A多药耐药基因mdr1表达的影响

目的：体外观察树突状细胞（dendritic cell,DC）联合细胞因子诱导的杀伤细胞（cytokine inducedkiller,CIK）对K562/A细胞株多药耐药基因mdr1表达的影响。方法：采集健康人的外周血,分离出单个核细胞（peripheral blood mononuclear cell,PBMC）,在体外加入多种细胞因子经诱导生成DC及CIK细胞,以流式细胞仪检测其表面标志,将DC细胞内加入K562/A细胞裂解物致敏后,再与CIK细胞混合培养48小时。将致敏后的DC-CIK细胞与K562/A及K562分组培养后以荧光定量PCR检测其mdr1基因表达的情况,PBMC作为对照组。结果：RT-PCR中可见K562/A＋DC-CIK组中mdr1 mRNA表达较K562/A明显降低,经荧光定量PCR观察到K562/A内mdr1 mRNA表达为K562的10.27倍、K562/A/PBMC略低于未处理的K562/A（P〉0.05）,K562/A/DC-CIK细胞中mdr1 mRNA含量较K562/A、K562/A/PBMC少（P〈0.05）。DC-CIK细胞与细胞株混合培养后,mdr1基因表达较混合培养前明显降低。结论：实验数据显示DC-CIK可使耐药细胞株内mdr1基因表达下调。但K562与DC-CIK混合培养后该基因降低不明显,提示该基因在细胞中存在着基础表达,意义在于维持细胞内稳态。目前针对逆转白血病耐药的研究较少,需要多进行相关研究以拓宽细胞免疫治疗在逆转耐药领域的应用。DC-CIK是具有发展潜力的抗肿瘤方法。本实验将为下一阶段研究逆转耐药的机制提供依据,DC-CIK细胞免疫疗法有望成为逆转肿瘤耐药的新方法。     

DADS 上调K562 细胞p21WAF1 表达对细胞生长阻抑和凋亡 的实验研究

目的:探讨二烯丙基二硫(DADS)对体外培养的人白血病细胞系K562细胞生长阻抑和凋亡作用及机制。方法:采用MTT分析法检测细胞活性、流式细胞术分析细胞周期及凋亡率、免疫组化检测p21WAF1基因表达。结果:1).DADS在10mg/L～80 mg/L范围内,对K562细胞的抑制作用呈剂量-时间依赖效应;2).不同浓度DADS作用于K562细胞24h后,细胞周期发生了变化:DADS可以将K562细胞阻滞于G2/M期;3).DADS浓度在10mg/L～80mg/L时作用K562细胞24h后,凋亡率逐渐升高,有显著的统计学意义(P<0.05或P<0.01);4).用浓度分别为0mg/L,20mg/L,40mg/L,80mg/L处理K562细胞24h后,p21WAF1蛋白表达上调,有统计学意义(P<0.05或P<0.01),溶媒组和阴性对照组无差别(P>0.05)。结论:DADS有抑制K562细胞增殖和促进K562细胞凋亡的作用。其作用的可能机制与上调细胞周期蛋白依赖性激酶抑制剂p21WAF1表达,从而诱使k562细胞阻滞于G2/M期有关。     

双氢青蒿素对人白血病细胞K562增殖及凋亡的影响

目的:研究双氢青蒿素对人白血病细胞增殖及凋亡的作用,探讨其对白血病的作用机制,为进一步研究提供依据。方法:体外培养K562细胞,用细胞计数法绘制生长曲线;流式细胞仪及荧光显微镜检测药物作用前后细胞凋亡作用;Western-blot测定药物作用前后线粒体、细胞浆细胞色素c的表达。结果:双氢青蒿素的浓度为1×10~(-4),1×10~(-5),1×10~(-6)l/L时,细胞生长受到显著抑制,并呈剂量依赖性;流式细胞仪检测出凋亡峰;Hoechst33342/PI双荧光染色可观察到明显的核浓缩、凝集等细胞凋亡表现;Western-blot检测1×10~(-5)mol/L药物处理细胞后线粒体细胞色素c表达水平下调1,细胞浆出现明显细胞色素c蛋白奈带。结论:双氢青蒿素能显著抑制人白血病细胞K562的生长,并诱导其凋亡,可能与线粒体途径有关。     

DC-CIK对K562/A多药耐药基因mdr1 表达的影响

目的：体外观察树突状细胞（dendritic cell，DC）联合细胞因子诱导的杀伤细胞（cytokine inducedkiller，CIK）对K562/A细胞株 多药耐药基因mdr1 表达的影响。方法：采集健康人的外周血，分离出单个核细胞( peripheral blood mononuclear cell，PBMC )，在 体外加入多种细胞因子经诱导生成DC及CIK 细胞，以流式细胞仪检测其表面标志，将DC 细胞内加入K562/A 细胞裂解物致敏 后，再与CIK细胞混合培养48 小时。将致敏后的DC-CIK 细胞与K562/A及K562 分组培养后以荧光定量PCR 检测其mdr1 基 因表达的情况，PBMC 作为对照组。结果：RT-PCR 中可见K562/A+DC-CIK 组中mdr1 mRNA 表达较K562/A明显降低，经荧光定 量PCR 观察到K562/A 内mdr1 mRNA 表达为K562 的10.27 倍、K562/A/PBMC 略低于未处理的K562/A（P>0.05）， K562/A/DC-CIK 细胞中mdr1 mRNA含量较K562/A、K562/A/PBMC 少（P<0.05）。DC-CIK细胞与细胞株混合培养后，mdr1 基因 表达较混合培养前明显降低。结论：实验数据显示DC-CIK 可使耐药细胞株内mdr1 基因表达下调。但K562 与DC-CIK 混合培养 后该基因降低不明显，提示该基因在细胞中存在着基础表达，意义在于维持细胞内稳态。目前针对逆转白血病耐药的研究较少， 需要多进行相关研究以拓宽细胞免疫治疗在逆转耐药领域的应用。DC-CIK 是具有发展潜力的抗肿瘤方法。本实验将为下一阶段 研究逆转耐药的机制提供依据，DC-CIK 细胞免疫疗法有望成为逆转肿瘤耐药的新方法。     

DC-CIK细胞的生物学活性及体外抗血液肿瘤研究

目的:研究细胞因子诱导的杀伤细胞(CIK)与树突状细胞(DC)共培养后的体外增殖能力、免疫表型变化、分泌细胞因子水平以及对K562、K562/ADM细胞毒作用的影响.方法:正常人外周血单个核细胞诱导DC和CIK细胞,将DC与CIK共培养,以CIK细胞单独培养为对照.用台盼蓝活细胞计数计算细胞扩增倍数,MTT法测定杀伤活性,流式细胞术分析免疫表型,ELISA双抗体夹心法检测分泌干扰素-γ(IFN-γ)、白细胞介素-12(IL-12)的水平.结果:DC-CIK细胞增殖能力明显高于CIK细胞(P＜0.05);DC、CIK细胞共培养后,CD3+ CD8+、CD3+ CD56+双阳性细胞比率较同条件下CIK细胞组显著增多(P＜0.05);共培养3d,DC-CIK细胞上清液中IL-12、INF-7的分泌量均比CIK细胞单独培养的分泌量高(P＜0.01,P＜ 0.05);在2.5∶1-20∶1的效靶比范围内,DC-CIK共培养物对K562和K562/ADM的杀伤活性均高于单纯CIK细胞组,且差异显著(P＜0.05),且杀伤率与效靶比呈正相关.结论:DC-CIK细胞的增殖能力、分泌细胞因子水平、对K562和K562/ADM的杀伤活性均高于CIK细胞,为DC-CIK细胞免疫治疗提供了实验和理论依据.     

过表达PTPα促进K562细胞体外增殖能力和体内致瘤性

探讨蛋白质酪氨酸磷酸酶α（PTPα）在血液肿瘤细胞中的特异性表达,研究过量表达PTPα对人红白血病细胞K562生物学行为的影响及在裸鼠体内致瘤能力的改变.首先应用RT-PCR和Western 印迹检测3种不同类型造血系肿瘤细胞（K562、NB4、Jurkat T）中PTPα的表达水平.根据检测结果,选择K562细胞作为研究对象,利用脂质体将 PTPα 真核表达载体转染K562细胞,通过G418筛选获得阳性克隆,RT-PCR和Western 印迹验证过表达情况;经MTT法检测细胞增值能力的改变;用流式细胞仪检测细胞周期分布和细胞分化状态;并将阳性克隆细胞皮下接种裸鼠,观察 PTPα 基因转染前后细胞系在裸鼠体内的致瘤能力及瘤体的组织化学变化.上述实验结果表明,通过G418压力筛选获得了 PTPα 高表达多克隆细胞系K562-PTPα;经体外增殖实验分析,实验组K562-PTPα细胞与未转染组细胞K562和转染空载体组细胞K562-splice相比,细胞生长速度增快,G₂/M期细胞比例增加( P <0.05),而细胞分化状态无明显变化;裸鼠体内致瘤实验显示,K562组、K562-splice组和K562 PTPα组平均瘤重分别为(1.1±0.3)g、(1.3±0.2)g和(2.5±0.5)g;病理切片显示,K562-PTPα组瘤体组织分化程度较对照组低、恶性程度高,细胞的致瘤能力增强( P <0.01).综上所述,过表达PTPα使K562细胞具有更强的体外增殖能力和体内致瘤性,表明PTPα可能在造血系统恶性肿瘤的发生发展中发挥促进作用.     

NPM1突变基因表达抑制K562白血病细胞体外增殖和侵袭

核仁磷酸蛋白(nucleophosmin,NPM1)突变是近年发现的在急性髓系白血病中发挥重要作用的基因改变,为探讨NPM1突变对K562白血病细胞体外增殖和侵袭能力的影响,将载体pEGFPC1-NPM1-mA转染K562细胞系,构建稳定表达NPM1突变蛋白的白血病细胞株(K562-mA)。利用细胞生长曲线观察细胞体外增殖能力;流式细胞仪检测细胞周期进程改变;细胞粘附、Transwell实验分别用以观察细胞体外粘附、迁移及侵袭能力。结果发现,NPM1突变转染后K562细胞体外增殖能力明显减弱;同时G1期细胞比例明显增高,S期细胞比例显著减低。与未处理组和空载体转染组细胞相比,K562-mA细胞体外迁移能力有所增加,但细胞粘附及侵袭能力却明显减弱。提示NPM1突变基因的表达能够抑制白血病细胞体外增殖和侵袭能力,为进一步深入探讨NPM1突变在白血病发生发展中的调控机制奠定了良好的基础。     

烷化溶血磷脂ET—18—OCH3对K562细胞作用的研究

为研究烷化溶血磷脂ET－18－OCH3（ALP）的抗白血病效果。本文以K562细胞为研究对象,通过台蓝拒染法测定ALP作用后K562细胞的生长抑制率和生长曲线;甲基纤维素半固体培养法测定克隆原细胞的存尖率;流式细胞仪检测K562细胞P210蛋白表达;TR－PCR半定量法测定细胞的bcr-abl mRNA;采用流式细胞仪进行DNA 及是民镜观察细胞形态学改变。结果显示,K562细胞经ALP处理后细胞生长明显受抑制,呈作用时间和剂量的依赖性,IC50为31.6(24h),22.3(48h),14.8(72h)μg/ml;细胞增殖速度显著降低,克隆原细胞存活曲线呈指数型,而正常对照组细胞的CFU－GM则未受影响;ATP还可使KT562细胞P210及bcr-abl mRNA水平下调,并有诱导细胞凋亡的作用,说明ALP对K562细胞生长具有明显抑制作用,并有诱导细胞凋亡的作用,提示ALP具有一定的抗白血病效应。     

酸性磷酸酶法检测体外培养细胞数

利用小鼠成纤维细胞系(NIH3T3)、小鼠骨髓瘤细胞系(SP2/0)、人大肠癌细胞系(LO-VO)和人白血病细胞系(K562),评价酸性磷酸酶(APA)法用于检测体外各类型细胞的增殖和杀伤作用。用直线回归分析光吸收度与每孔活细胞数的关系。结果表明,APA法能准确地反映检测的活细胞数(相关系数均>0.99)。本方法不仅能很好地检测表皮生长因子对细胞的增殖作用,也能够检测顺铂对体外细胞的杀伤作用。结果表明APA法简单、灵敏,可以用于上皮和间质等贴壁和悬浮生长的细胞计数。     

Antizyme1基因转染对K562细胞增殖与凋亡的影响

研究鸟氨酸脱羧酶抗酶蛋白对人红白血病K562细胞增殖、三氧化二砷（ As2O3）诱导凋亡时的影响。方法: 定点突变技术构建缺失frameshift位点的pEGFP-N1-AZ1-mutation重组表达载体。脂质体法转染K562细胞,通过G418筛选获得稳定表达antizyme1的K562pAZ1m细胞系。采用不同浓度的As2O3处理细胞,通过MTT法检测细胞增殖,流式细胞术分析细胞周期及凋亡变化。并通过RT-PCR方法检测antiyme1转染对cyclin D1和survivin基因表达的影响。结果：获得稳定表达antizyme1的K562-AZ1m细胞株后,其增殖能力明显减慢。CyclinD1基因表达降低,细胞主要停滞于G0/G1期。在 As2O3的诱导作用下,细胞凋亡增多,survivin基因表达降低。结论：AZ1基因能够抑制K562细胞增殖,通过对cyclinD1的负调控使细胞周期停滞于G0/G1期。并可能通过下调survivin表达来加强 As2O3对其的诱导凋亡作用     

Protective effect of Bosutinib with caspase inhibitors on human K562 cells

IntroductionCancer therapy has become increasingly focused on molecularly targeted medications. Despite the fact that multi-cytotoxic medication regimens have proven to be highly effective, many investigations in targeted treatments have focused on a single agent. The precise molecular mechanism of action of second-generation BCR–ABL tyrosine kinase inhibitors, which includes different targets and pathways, can help rationalize therapy in chronic myelogenous leukemia (CML) and other diseases affected by BCR–ABL tyrosine kinase inhibitors (TKIs).AimThe purpose of this study was to analyze if bosutinib (BOS) combined with Boc-D-FMK effectively suppressed proliferation and induced apoptosis in K562 cells to a lesser extent, implying that bosutinib is an effective leukemia treatment and that its combination with Boc-D-FMK is a mild chemotherapeutic agent against leukemia.MethodsIn this study, bosutinib was obtained together with other materials to perform a cell culture experiment with human cell lines, as well as additional drug treatment. Furthermore, cell viability (MTT assay) and flow cryometry such as viability and cell cycle assays are performed. The target profile of the dual SRC/ABL inhibitor bosutinib was studied in this study as a first kinase inhibitor to target K562 cells, which has recently been linked to the proliferation of myelogenous leukaemia cells, these results suggest the effectiveness of inhibitory activity on cell viability/proliferation, alone generated a potent value of 250 nM (39.27 ± 1.17) for 48 h as optimal dose.ResultsThe cytotoxic effect of bosutinib on the K562 cell line was assessed in vitro using the MTT assay, and the cytotoxicity was further clarified using cell viability and cell cycle assays. Guava Cell Assay software validated the activation of apoptosis. Sub-G1, G0/G1, S, and G2/M phases are depicted. Cell cycle research revealed that K562 cells treated with bosutinib accumulated much more in the sub-G1 phase, which was later validated by a drop peak at the G2/M phase.ConclusionIn conclusion, the nature of bosutinib's reduction of cancer cell growth may open the door to future research into the development of green synthesis medicines, particularly for cancer treatment.     

Electrochemical immunoassay of membrane P-glycoprotein by immobilization of cells on gold nanoparticles modified on a methoxysilyl-terminated butyrylchitosan matrix

A strategy to detect P-glycoprotein (P-gp) on cell membrane and quantify the cell number using electrochemical immunoassay was developed by effective surface immunoreactions and immobilization of cells on a highly hydrophilic interface, which was constructed by adsorption of colloidal gold nanoparticles on a methoxysilyl-terminated (Mos) butyrylchitosan modified glassy carbon electrode (Au-CS/GCE). Atomic force microscopy studies proved that the nanoparticles adsorbed on Mos-butyrylchitosan were efficient in preventing the cell leakage and retaining the activity of immobilized living K562/ADM leukemic cells. The incubation with P-gp monoclonal antibody and then the secondary alkaline phosphatase (AP) conjugated antibody introduced AP onto the K562/ADM cell immobilized on Au-CS/GCE. The bound AP led to an amperometric response of 1-naphthyl phosphate. Under optimal conditions the response was proportional to the logarithm of cell concentration in the range from 5.0 x 10(4) to 1.0 x 10(7) cells mL(-)(1) with a detection limit of 1.0 x 10(4) cells mL(-)(1). The results were comparable to flow cytometric analysis of P-gp expression. This proposed method was practical, convenient, and significant in the clinic and cytobiology.     

紫菜多糖对免疫细胞及肿瘤细胞生长的影响（英文）

采用细胞培养技术测定从条斑紫菜中得到的多糖PY3对小鼠免疫细胞及人肿瘤细胞K562生长的影响。结果表明,PY3对小鼠骨髓细胞和脾脏淋巴细胞的增殖以及对混合淋巴细胞反应均有一定的促进作用。PY3对血癌细胞K562的生长有一定的抑制作用,研究表明多糖PY3不仅能够提高小鼠免疫细胞的功能,而且有一定的抗肿瘤作用。     

Nanovid tracking: a new automatic method for the study of mobility in living cells based on colloidal gold and video microscopy.

We describe a new automatic technique for the study of intracellular mobility. It is based on the visualization of colloidal gold particles by video-enhanced contrast light microscopy (nanometer video microscopy) combined with modern tracking algorithms and image processing hardware. The approach can be used for determining the complete statistics of saltatory motility of a large number of individual moving markers. Complete distributions of jump time, jump velocity, stop time, and orientation can be generated. We also show that this method allows one to study the characteristics of random motion in the cytoplasm of living cells or on cell membranes. The concept is illustrated by two studies. First we present the motility of colloidal gold in an in vitro system of microtubules and a protein extract containing a kinesin-like factor. The algorithm is thoroughly tested by manual tracking of the videotapes. The second study involves the motion of gold particles microinjected in the cytoplasm of PTK-2 cells. Here the results are compared to a study using the spreading of colloidal gold particles after microinjection.     

Lactoferrin binding sites and nuclear localization in K562(S) cells.

Lactoferrin, a single chain cationic glycoprotein, present in the secondary granules of neutrophils, acts as a negative feedback regulator of myelopoiesis. Specific receptors for lactoferrin were detected on the surface of different hematopoietic cell types. The influence of lactoferrin on cell growth in culture has been reported. Interactions of lactoferrin with DNA were also demonstrated. In the present paper we confirm the presence of lactoferrin specific binding sites on K562 cells and we estimate the number of binding sites and the dissociation constant. By Western blotting analysis performed on K562 lysates we find a band of about 120 kDa responsible for specific binding of lactoferrin. We also show that lactoferrin, after binding at the cell surface, is internalized in a temperature dependent way and is immunologically detectable as a DNA-linked protein in nuclear extracts.